Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components

The aim of this study was to compare the cost-utility of the first available single-pill triple combination antihypertensive therapy containing valsartan (V), amlodipine (A) and hydrochlorothiazide (H), with each of the same components dual combinations in patients with moderate to severe hypertensi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cost Eff Resour Alloc
Autori principali: Stafylas, Panagiotis, Kourlaba, Georgia, Hatzikou, Magda, Georgiopoulos, Dimitrios, Sarafidis, Pantelis, Maniadakis, Nikolaos
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2015
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4474457/
https://ncbi.nlm.nih.gov/pubmed/26097434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-015-0036-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi